Cargando…
How much can improved molecular and pathologic discriminants change local therapy?
Autor principal: | Morrow, Monica |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614857/ https://www.ncbi.nlm.nih.gov/pubmed/19128443 http://dx.doi.org/10.1186/bcr2165 |
Ejemplares similares
-
Decision making in local therapy for breast cancer
por: Morrow, Monica
Publicado: (2007) -
By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016) -
Introduction to sessions on 'What can surgeons do for us (and we for them): radiology, pathology, molecular biology and local therapy'
por: Dixon, J Michael, et al.
Publicado: (2008) -
Lung ultrasound: are we diagnosing too much?
por: Volpicelli, Giovanni, et al.
Publicado: (2023) -
Perioperative fluid therapy: How much is not too much?
por: Gurudatt, CL
Publicado: (2012)